Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Brooke Bernhardt

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Pediatric Blood & Cancer|July 9, 2015
Inpatient versus outpatient vincristine, dactinomycin, and cyclophosphamide for pediatric cancers: Quality and cost implicationsRachel S Beaty, M Brooke Bernhardt, Amanda H Berger, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 10, 2017
Evaluation of opioid prescribing after rescheduling of hydrocodone-containing productsM Brooke Bernhardt, Ruston S Taylor, Joseph L Hagan, et al.
Pediatric Blood & Cancer|September 7, 2022
Safety analysis of high-dose methotrexate in pediatric non-Hodgkin lymphomasM Brooke Bernhardt, Austin L Brown, Austyn T Grim, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 6, 2026
Stability of extemporaneously compounded cobimetinib oral suspensionsSophia Tilley, Yong Li, Cynthia A Brasher, et al.
Cancer|October 8, 2021
Rising drug cost impacts on cost-effectiveness of 2 chemotherapy regimens for intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology GroupHeidi V Russell, Yueh-Yun Chi, M Fatih Okcu, et al.
Pediatric Blood & Cancer|February 16, 2019
Fundamental problems with pediatric adaptive dosing of carboplatin using nuclear-medicine-based estimates of renal functionPeter C Adamson, Gareth J Veal, Richard B Womer, et al.
Pediatric Blood & Cancer|August 10, 2017
Rapid infusion of rituximab is well tolerated in children with hematologic, oncologic, and rheumatologic disordersM Brooke Bernhardt, Marietta M De Guzman, Amanda Grimes, et al.
British Journal of Haematology|April 19, 2017
Pharmacogenetic association with neurotoxicity in Hispanic children with acute lymphoblastic leukaemiaClaire A McClain, M Brooke Bernhardt, Amanda Berger, et al.
Pediatric Blood & Cancer|July 17, 2023
Children's Oncology Group's 2023 blueprint for research: PharmacyAndrew R Ostrenga, Jennifer Thackray, Ha-Mill H McLearan, et al.
Pharmacotherapy|April 21, 2026
Impact of Dosing Interval Adherence on Pharmacokinetic Outcomes of Recombinant Erwinia Asparaginase in Pediatric Leukemia or LymphomaMilre M Matherne, John C Panetta, Jaclyn Hopp, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Pediatric Blood & Cancer|July 9, 2015
Inpatient versus outpatient vincristine, dactinomycin, and cyclophosphamide for pediatric cancers: Quality and cost implicationsRachel S Beaty, M Brooke Bernhardt, Amanda H Berger, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 10, 2017
Evaluation of opioid prescribing after rescheduling of hydrocodone-containing productsM Brooke Bernhardt, Ruston S Taylor, Joseph L Hagan, et al.
Pediatric Blood & Cancer|September 7, 2022
Safety analysis of high-dose methotrexate in pediatric non-Hodgkin lymphomasM Brooke Bernhardt, Austin L Brown, Austyn T Grim, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 6, 2026
Stability of extemporaneously compounded cobimetinib oral suspensionsSophia Tilley, Yong Li, Cynthia A Brasher, et al.
Cancer|October 8, 2021
Rising drug cost impacts on cost-effectiveness of 2 chemotherapy regimens for intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology GroupHeidi V Russell, Yueh-Yun Chi, M Fatih Okcu, et al.
Pediatric Blood & Cancer|February 16, 2019
Fundamental problems with pediatric adaptive dosing of carboplatin using nuclear-medicine-based estimates of renal functionPeter C Adamson, Gareth J Veal, Richard B Womer, et al.
Pediatric Blood & Cancer|August 10, 2017
Rapid infusion of rituximab is well tolerated in children with hematologic, oncologic, and rheumatologic disordersM Brooke Bernhardt, Marietta M De Guzman, Amanda Grimes, et al.
British Journal of Haematology|April 19, 2017
Pharmacogenetic association with neurotoxicity in Hispanic children with acute lymphoblastic leukaemiaClaire A McClain, M Brooke Bernhardt, Amanda Berger, et al.
Pediatric Blood & Cancer|July 17, 2023
Children's Oncology Group's 2023 blueprint for research: PharmacyAndrew R Ostrenga, Jennifer Thackray, Ha-Mill H McLearan, et al.
Pharmacotherapy|April 21, 2026
Impact of Dosing Interval Adherence on Pharmacokinetic Outcomes of Recombinant Erwinia Asparaginase in Pediatric Leukemia or LymphomaMilre M Matherne, John C Panetta, Jaclyn Hopp, et al.
Pageof 5